OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The safety and efficacy of TACE combined with HAIC, PD-1 inhibitors, and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: a retrospective study
Zhong-Jing Huang, Ziyi Wu, Lidong Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Zhong-Jing Huang, Ziyi Wu, Lidong Zhang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 4
Showing 4 citing articles:
Research Status and Progress of Transcatheter Arterial Chemoembolization Combined with Transcatheter Arterial Chemoembolization in the Treatment of Primary Liver Cancer
秋吉 韦
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1558-1566
Closed Access
秋吉 韦
Advances in Clinical Medicine (2025) Vol. 15, Iss. 01, pp. 1558-1566
Closed Access
Lenvatinib and tislelizumab versus atezolizumab and bevacizumab in combination with TAE-HAIC for unresectable hepatocellular carcinoma with high tumor burden: a multicenter retrospective cohort study
Hongjie Cai, Song Chen, Shuang‐Yan Tang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Hongjie Cai, Song Chen, Shuang‐Yan Tang, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
Current Status and Progress of Hepatic Artery Perfusion Chemotherapy and Hepatic Artery Chemoembolization in the Treatment of Unresectable Hepatocellular Carcinoma
少奇 祖
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 826-831
Closed Access
少奇 祖
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 826-831
Closed Access
The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients
Zhengzheng Ji, J. Li, Shasha Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Zhengzheng Ji, J. Li, Shasha Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
